Skip to main content
logo
Algorae Pharmaceuticals Limited (ASX:1AI)
Australia flag Australia · Delayed Price · Currency is AUD
0.0090
0.00 (0.00%)
Sep 18, 2026, 2:45 PM AEST

Algorae Pharmaceuticals Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
-----0
Revenue Growth
------98.73%
Gross Profit
-----0
Operating Income
-2.29-2.29-1.07-1.7-1.52-1.46
Net Income
-2.71-2.71-0.8-2.1-2.11-1.96
Earnings Per Share
-0.00-0.00-0.00-0.00-0.00-0.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
3.943.942.323.114.114.24
Total Debt
------
Net Cash (Debt)
3.943.942.323.114.114.24
Net Cash Growth
109.08%69.77%-25.39%-24.39%-3.02%162.92%
Net Cash Per Share
0.000.000.000.000.000.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-2.6-2.6-0.79-1.52-1.99-2.04
Capital Expenditures
------0
Free Cash Flow
-2.6-2.6-0.79-1.52-1.99-2.05
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
-----100.00%
Operating Margin
------42870.16%
Pretax Margin
------69663.11%
Profit Margin
------57483.11%
FCF Margin
------60088.31%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
-----3019.57